IRONMAN adds support for iron repletion in HF

The IRONMAN trial adds further support to the known benefits of intravenous iron therapy in patients with heart failure (HF) with reduced ejection fraction and iron deficiency, but narrowly misses the primary end point of hospitalization for HF and cardiovascular death.

Detalles Bibliográficos
Autor principal: Fernández-Ruiz, Irene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Research Highlight
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684863/
https://www.ncbi.nlm.nih.gov/pubmed/36414679
http://dx.doi.org/10.1038/s41569-022-00815-5
_version_ 1784835381638725632
author Fernández-Ruiz, Irene
author_facet Fernández-Ruiz, Irene
author_sort Fernández-Ruiz, Irene
collection PubMed
description The IRONMAN trial adds further support to the known benefits of intravenous iron therapy in patients with heart failure (HF) with reduced ejection fraction and iron deficiency, but narrowly misses the primary end point of hospitalization for HF and cardiovascular death.
format Online
Article
Text
id pubmed-9684863
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-96848632022-11-28 IRONMAN adds support for iron repletion in HF Fernández-Ruiz, Irene Nat Rev Cardiol Research Highlight The IRONMAN trial adds further support to the known benefits of intravenous iron therapy in patients with heart failure (HF) with reduced ejection fraction and iron deficiency, but narrowly misses the primary end point of hospitalization for HF and cardiovascular death. Nature Publishing Group UK 2022-11-21 2023 /pmc/articles/PMC9684863/ /pubmed/36414679 http://dx.doi.org/10.1038/s41569-022-00815-5 Text en © Springer Nature Limited 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Research Highlight
Fernández-Ruiz, Irene
IRONMAN adds support for iron repletion in HF
title IRONMAN adds support for iron repletion in HF
title_full IRONMAN adds support for iron repletion in HF
title_fullStr IRONMAN adds support for iron repletion in HF
title_full_unstemmed IRONMAN adds support for iron repletion in HF
title_short IRONMAN adds support for iron repletion in HF
title_sort ironman adds support for iron repletion in hf
topic Research Highlight
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684863/
https://www.ncbi.nlm.nih.gov/pubmed/36414679
http://dx.doi.org/10.1038/s41569-022-00815-5
work_keys_str_mv AT fernandezruizirene ironmanaddssupportforironrepletioninhf

Ejemplares similares